See more : OUG Holdings Inc. (8041.T) Income Statement Analysis – Financial Results
Complete financial analysis of Ship Healthcare Holdings, Inc. (3360.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ship Healthcare Holdings, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Public Joint Stock Company Territorial Generating Company No. 1 (TGKA.ME) Income Statement Analysis – Financial Results
- Tatung System Technologies Inc. (8099.TWO) Income Statement Analysis – Financial Results
- Healthpeak Properties, Inc. (PEAK) Income Statement Analysis – Financial Results
- Elecster Oyj (ELEAV.HE) Income Statement Analysis – Financial Results
- China Conch Venture Holdings Limited (0586.HK) Income Statement Analysis – Financial Results
Ship Healthcare Holdings, Inc. (3360.T)
About Ship Healthcare Holdings, Inc.
Ship Healthcare Holdings, Inc. engages in the medical, healthcare, welfare, and nursing care businesses worldwide. It operates through four segments: Total Pack Produce Business, Medical Supply Business, Lifecare Business, and Dispensing Pharmacy Business. The Total Pack Produce segment engages in sale of medical devices and medical equipment based on bulk orders; offers consulting services on medicine, healthcare, welfare, and nursing care facilities; and leasing of real estate to medical facilities and other tenants. The Medical Supply segment sells medical examination and treatment materials, and special treatment materials. The Life Care segment operates homes for senior citizens, group homes, and other facilities and nutritional services. The Dispensing Pharmacy segment operates dispensing pharmacies. The company was incorporated in 1992 and is headquartered in Suita, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 630.99B | 572.29B | 514.35B | 497.16B | 484.40B | 444.05B | 425.57B | 408.49B | 306.85B | 273.33B | 259.19B | 224.36B | 188.84B | 162.43B | 140.01B | 118.60B | 105.87B | 78.85B | 62.23B | 52.86B |
| Cost of Revenue | 565.38B | 511.67B | 460.71B | 442.67B | 434.77B | 397.40B | 378.48B | 363.99B | 270.18B | 238.21B | 225.63B | 193.40B | 161.76B | 139.26B | 120.87B | 103.12B | 91.94B | 68.82B | 54.39B | 45.51B |
| Gross Profit | 65.61B | 60.62B | 53.64B | 54.49B | 49.63B | 46.65B | 47.08B | 44.50B | 36.67B | 35.12B | 33.56B | 30.96B | 27.08B | 23.17B | 19.14B | 15.49B | 13.93B | 10.03B | 7.84B | 7.35B |
| Gross Profit Ratio | 10.40% | 10.59% | 10.43% | 10.96% | 10.25% | 10.51% | 11.06% | 10.89% | 11.95% | 12.85% | 12.95% | 13.80% | 14.34% | 14.26% | 13.67% | 13.06% | 13.16% | 12.72% | 12.60% | 13.91% |
| Research & Development | 393.00M | 350.00M | 399.00M | 360.00M | 341.00M | 263.00M | 350.00M | 333.00M | 456.00M | 595.00M | 551.00M | 454.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.84B | 1.73B | 1.52B | 1.51B | 1.42B | 1.44B | 1.47B | 1.45B | 1.30B | 1.23B | 1.16B | 1.12B | 1.62B | 1.44B | 1.35B | 1.20B | 1.00B | 1.24B | 905.00M | 991.09M |
| Selling & Marketing | 39.33B | 37.73B | 31.38B | 31.81B | 29.03B | 27.40B | 26.99B | 26.80B | 20.79B | 20.71B | 18.57B | 17.18B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 40.77B | 39.46B | 32.90B | 33.32B | 30.45B | 28.84B | 28.46B | 28.24B | 22.08B | 21.95B | 19.72B | 18.30B | 1.62B | 1.44B | 1.35B | 1.20B | 1.00B | 1.24B | 905.00M | 991.09M |
| Other Expenses | 0.00 | 437.00M | 255.00M | 244.00M | 218.00M | 192.00M | 28.82B | 309.00M | 324.00M | 234.00M | 225.00M | 263.48M | 1.11B | 848.84M | 360.71M | 190.74M | -203.73M | 106.75M | 71.43M | -125.47M |
| Operating Expenses | 41.17B | 39.47B | 33.14B | 32.68B | 30.83B | 28.70B | 28.82B | 28.44B | 22.62B | 21.52B | 19.70B | 18.42B | 7.45B | 6.80B | 6.04B | 5.21B | 4.54B | 2.96B | 1.94B | 2.31B |
| Cost & Expenses | 606.55B | 551.14B | 493.85B | 475.35B | 465.60B | 426.09B | 407.30B | 392.43B | 292.80B | 259.73B | 245.33B | 211.82B | 169.21B | 146.06B | 126.91B | 108.33B | 96.49B | 71.78B | 56.33B | 47.82B |
| Interest Income | 330.00M | 310.00M | 289.00M | 313.00M | 391.00M | 306.00M | 301.00M | 336.00M | 324.00M | 326.00M | 381.00M | 340.58M | 368.27M | 536.86M | 640.12M | 644.65M | 828.38M | 574.62M | 283.16M | 177.94M |
| Interest Expense | 449.00M | 424.00M | 283.00M | 325.00M | 268.00M | 258.00M | 254.00M | 287.00M | 292.00M | 351.00M | 353.00M | 348.14M | 390.25M | 438.88M | 575.25M | 713.12M | 552.06M | 324.62M | 257.20M | 250.92M |
| Depreciation & Amortization | 7.44B | 7.45B | 5.49B | 5.13B | 4.85B | 4.50B | 4.19B | 4.67B | 4.50B | 3.85B | 3.42B | 3.13B | 1.93B | 2.32B | 2.62B | 2.65B | 4.76B | 1.42B | 929.22M | 448.21M |
| EBITDA | 29.75B | 28.61B | 26.23B | 26.30B | 24.99B | 23.29B | 21.86B | 21.04B | 18.48B | 17.92B | 18.34B | 16.91B | 14.08B | 10.97B | 8.80B | 13.76B | 541.00M | 6.86B | 7.18B | 5.55B |
| EBITDA Ratio | 4.72% | 4.97% | 5.21% | 5.60% | 5.07% | 5.22% | 5.44% | 5.22% | 6.26% | 6.60% | 6.90% | 7.26% | 12.21% | 12.37% | 11.95% | 11.60% | 13.95% | 11.63% | 11.54% | 10.49% |
| Operating Income | 24.44B | 21.14B | 20.51B | 21.80B | 18.79B | 17.95B | 18.26B | 16.06B | 14.05B | 13.60B | 13.86B | 12.54B | 19.63B | 16.37B | 13.10B | 10.28B | 9.38B | 7.07B | 5.90B | 5.05B |
| Operating Income Ratio | 3.87% | 3.69% | 3.99% | 4.38% | 3.88% | 4.04% | 4.29% | 3.93% | 4.58% | 4.97% | 5.35% | 5.59% | 10.40% | 10.08% | 9.36% | 8.67% | 8.86% | 8.97% | 9.48% | 9.54% |
| Total Other Income/Expenses | -2.58B | -479.00M | 299.00M | -565.00M | 1.08B | 538.00M | -846.00M | 23.00M | -359.00M | 123.00M | 710.00M | 885.22M | 900.42M | 205.53M | 31.52M | -5.91B | -10.54B | -1.95B | -2.58B | -2.55B |
| Income Before Tax | 21.86B | 20.67B | 20.80B | 21.24B | 19.87B | 18.49B | 17.41B | 16.08B | 13.69B | 13.72B | 14.57B | 13.43B | 11.10B | 8.14B | 5.73B | 4.37B | -1.16B | 5.11B | 3.32B | 2.49B |
| Income Before Tax Ratio | 3.46% | 3.61% | 4.04% | 4.27% | 4.10% | 4.16% | 4.09% | 3.94% | 4.46% | 5.02% | 5.62% | 5.99% | 5.88% | 5.01% | 4.09% | 3.68% | -1.10% | 6.49% | 5.33% | 4.72% |
| Income Tax Expense | 8.12B | 9.06B | 8.42B | 8.87B | 8.04B | 7.41B | 6.92B | 6.54B | 4.73B | 6.16B | 5.99B | 4.76B | 3.90B | 2.07B | 2.31B | 2.07B | 2.38B | 2.43B | 1.64B | 1.19B |
| Net Income | 13.79B | 12.06B | 12.17B | 12.28B | 11.80B | 11.24B | 10.35B | 9.41B | 8.85B | 7.47B | 8.52B | 8.59B | 7.03B | 5.93B | 3.15B | 2.05B | -3.77B | 2.47B | 1.70B | 1.31B |
| Net Income Ratio | 2.19% | 2.11% | 2.37% | 2.47% | 2.44% | 2.53% | 2.43% | 2.30% | 2.88% | 2.73% | 3.29% | 3.83% | 3.72% | 3.65% | 2.25% | 1.73% | -3.56% | 3.13% | 2.73% | 2.47% |
| EPS | 146.15 | 127.85 | 129.01 | 129.99 | 124.01 | 113.87 | 102.27 | 93.16 | 89.54 | 84.23 | 105.59 | 104.08 | 85.16 | 71.88 | 4.26K | 30.74 | -56.40 | 36.95 | 28.63 | 145.13 |
| EPS Diluted | 146.15 | 115.93 | 117.02 | 117.95 | 112.62 | 110.55 | 102.27 | 93.16 | 89.54 | 84.23 | 104.80 | 103.89 | 85.16 | 71.88 | 4.26K | 30.74 | -56.40 | 36.95 | 28.63 | 145.13 |
| Weighted Avg Shares Out | 94.35M | 94.35M | 94.35M | 94.47M | 95.18M | 98.67M | 101.20M | 101.01M | 98.81M | 88.72M | 80.73M | 82.54M | 82.51M | 82.51M | 74.05M | 66.80M | 66.80M | 66.80M | 57.96M | 43.97M |
| Weighted Avg Shares Out (Dil) | 94.35M | 103.92M | 103.88M | 103.97M | 104.66M | 101.63M | 101.20M | 101.01M | 98.81M | 88.72M | 81.33M | 82.68M | 82.51M | 82.51M | 74.05M | 66.80M | 66.80M | 66.80M | 57.96M | 43.97M |
Source: https://incomestatements.info
Category: Stock Reports